NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Cancer Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . May 4th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Cancer Vaccine Week | Other Publications

Cancer Vaccines - Newly published study shows that re-treatment with Pegasys® (peginterferon alfa-2a) provides hepatitis C patients with a second chance for a cure

Cancer Vaccines - Reports from Baylor College of Medicine, College of Medicine describe recent advances in cancer vaccines

Cancer Vaccines - Researchers from University of Georgia report details of new studies and findings in the area of cancer vaccines

Cancer Vaccines - Study results from S.U. Ahmed and colleagues broaden understanding of cancer vaccines

Life Sciences - Investigators at Johns Hopkins University, Medical Department release new data on life sciences

Research and Markets - World Vaccines Market 2008-2013 Future Forecast, Critical Trends and Developments

Cancer Vaccines - Researchers from Ludwig-Maximilians University, Department of Internal Medicine describe findings in cancer vaccines

Hepatitis B Virus Risk Factors - New data from Yale University illuminate research in hepatitis B virus risk factors

Vaccines - Researchers at Dana-Farber Cancer Institute release new data on vaccines

Advaxis, Inc - Advaxis in Drug Licensing Discussions for Its Flagship Vaccine Construct, ADXS11-001

Cancer Vaccines - Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer

ERYtech Pharma - ERYtech Pharma Presents Very Encouraging Results of Its R&D Platform at the AACR in Denver

Kureczka/Martin Associates - Microparticle immune response modifier shows broad effects against recurrent or metastatic cancer

NanoBio Corp. - NanoBio Initiates FDA Approved Clinical Trial for Adjuvanted Intranasal Influenza Vaccine



Return to Top of Page

-----------------------
PR Login